Parenteral medications are sterile dose forms that are supplied by means other than the oral route. They are injected into one or more layers of skin, with the active substance coming into direct touch with tissue or blood vessels. Small volume parenteral is a single or multi-dose preparation with a volume of 100 ml or less, whereas large volume parenteral has a volume greater than 100 ml. Large volume parenteral comes in a bag or container for intravenous administration and is used for fluid/electrolyte balance correction as well as feeding such as dextrose.
A Large
Volume Parenteral Market is a unit dose container larger than 100ml
that has been heating sterilized. Except for biologicals, small-volume parenteral
(SVP) is a catch-all term for all non-LVP parenteral.
This
report on the Large Volume Parenteral
Market details
new recent developments, trade regulations, import-export analysis, production
analysis, value chain optimization, market share, the impact of domestic and
localized market players, analyses opportunities in terms of emerging revenue
pockets, changes in market regulations, strategic market growth analysis,
market size, category market growths, application niches and dominance, product
approvals, product launches, and so on.
Parenteral
preparations are sterile, solid dosage forms or pyrogen-free liquids containing
one or more active substances in single or multiple-dose containers. They are
intended to be delivered to the body via infusion, transplantation, or
injection. Parenteral formulations are divided into two categories based on
their volume: small and large. Large Volume Parenteral
Market parenteral
formulations are 100ml or less and can be administered as single or multiple
doses, whereas big volume parenteral preparations are greater than 100ml and
designed for single usage. The reasons driving this market include an increase
in hospitalization rates and an increase in demand for faster, safer, and more
effective drug administration. The emergence of single-dose treatments for
nervous system illnesses, oncology, and diabetes would create the potential for
this industry to flourish.
Key players
Baxter International Inc., Teva Pharmaceutical
Industries Limited, Kelun Pharmaceutical Inc., BAG Healthcare GmbH, Hospira,
Inc., Patheon Inc., Otsuka Pharmaceutical, Wockhardt Ltd., Southwest
Pharmaceutical Co. Ltd., and Cook Pharmica LLC are key competitors in the large
volume parenteral industry.
0 Comments